Wednesday, 25 February 2026 | 11:00 - 11:50
PANEL DISCUSSION: DEMYSTIFYING AI IN PHARMACOVIGILANCE
Location:Gloria B, C, D
-
Common Assumption: Human-in-the-loop automatically solves risk
-
Common Assumption: Validation is something you do once, then move on
-
Common Assumption: If it is accurate, it is compliant
-
Common Assumption: More data automatically leads to better AI
-
The hype vs reality in applications of AI in PV risk management
4 speakers
Chief Customer Officer
Synapmed
Global Head Medical Safety
Organon
Global Safety Director, EU/ EEA QPPV
Indivior
Head of Global Pharmacovigilance, QPPVEU
Worwag Pharma
Location image